Relationship between contrast sensitivity, vision-related quality of life and foveal microstructure in patients with diabetic macular edema following aflibercept therapy.
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Jun 2017 Status changed from not yet recruiting to recruiting.
- 23 May 2016 New trial record